Axsome Therapeutics AXSM Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $305.11M+1.4% | $322.93M+2.4% | $325.27M-0.6% | $303.02M-4.0% | $300.91M-9.2% | ||
| $251.06M+55.6% | $224.46M+58.1% | $196.51M+58.4% | $198.83M+65.2% | $161.4M+59.1% | ||
| $31.52M+93.1% | $27.94M+77.6% | $23.77M+66.7% | $18.44M+21.2% | $16.32M+4.7% | ||
| $611.21M+23.6% | $588.99M+21.4% | $565.34M+18.0% | $536.62M+15.9% | $494.63M+7.4% | ||
| $567K-26.6% | $562K-3.8% | $605K-11.4% | $667K-7.9% | $773K-4.8% | ||
| $12.04M0.0% | $12.04M0.0% | $12.04M0.0% | $12.04M0.0% | $12.04M0.0% | ||
| $38.95M-14.1% | $40.52M-13.6% | $42.13M-13.1% | $43.73M-12.7% | $45.32M-12.3% | ||
| $713.61M+19.6% | $689.81M+21.3% | $669.25M+19.2% | $639.79M+16.7% | $596.67M+9.3% | ||
| $106.7M+24.6% | $65.54M-9.0% | $54.23M-15.6% | $91.63M+49.4% | $85.66M+59.2% | ||
| $70M— | $70M— | $70M— | $70M— | —— | ||
| $439.21M+80.1% | $378.84M+64.6% | $360.29M+83.6% | $342.1M+83.4% | $243.91M+69.3% | ||
| $117.85M-35.0% | $117.75M-34.8% | $117.64M-34.6% | $117.54M-34.5% | $181.38M+1.5% | ||
| $659.02M+21.3% | $601.51M+17.6% | $595.52M+27.1% | $566.71M+27.2% | $543.47M+35.3% | ||
| $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | $5K0.0% | ||
| -$1.37B-15.9% | -$1.31B-16.3% | -$1.28B-21.9% | -$1.23B-25.1% | -$1.18B-30.8% | ||
| $54.59M+2.6% | $88.3M+54.9% | $73.73M-20.6% | $73.08M-29.0% | $53.21M-63.1% | ||
| $713.61M+19.6% | $689.81M+21.3% | $669.25M+19.2% | $639.79M+16.7% | $596.67M+9.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Axsome Therapeutics's total assets?
- Axsome Therapeutics (AXSM) holds $713.6M in total assets, up 19.6% year over year.
- How much debt does Axsome Therapeutics have?
- Axsome Therapeutics carries $219.9M in total debt against $54.6M of shareholders' equity, a debt-to-equity ratio of 4.03.
- How much cash does Axsome Therapeutics have?
- Axsome Therapeutics holds $305.1M in cash and equivalents.
- Can Axsome Therapeutics cover its short-term obligations?
- Its current ratio is 1.39 — current assets exceed current liabilities.
- Where does Axsome Therapeutics's balance sheet data come from?
- Every line is extracted from Axsome Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
